With this interactive audio conference, FDC/Windhover’s pharma director Roger Longman and IN VIVO editor Christopher Morrison will deliver the key biopharma insights and advice they and the entire Windhover team garnered not just from the meeting's sessions, but from the many one-on-one conversations we had with the event's senior-level attendees.

When taken together, these insights paint the clearest "in the know" picture of what's to come in health-care strategy, financings, M&A, alliances and the venture-capital world.

Windhover's team is consistently ahead of the curve in identifying biopharmaceutical industry trends. Prepare yourself and your teams for the challenges of the new year!

The discussion is backed by proprietary FDC/Windhover data, delivered in a convenient audio conference format, and capped off with an interactive Q&A round.

We've done the research for you and compiled a list of all the companies that will be presenting at the conference, with links to Windhover's company profiles. Start viewing the company profiles with added preview of related articles now!

Click here for more information on JP Morgan Presenting Companies

So join us, in the convenience of your own office, for a thought-provoking analysis by FDC/Windhover's expert editorial team. Grab your team (or several teams), a conference room at your office, a phone and a computer with Web access (that last one's optional). No travel required.

Key discussion highlights include:

• What's the buzz in biotech alternative financing and M&A? Are there product or therapeutic categories ripe for dealmaking? Specific deals in the works?
• Which rumors are merely rumors, which make a lot of sense and why, and which are likely to produce the next big deal?
• How will Big Pharma react to the new wave of genericizations, restricted approvals, and reimbursement hurdles? More follow-on biologics? More aggressive option deals?  New financing techniques for their own R&D? Something no one’s talking about yet?
• And, of course, the insights and findings Windhover's team has captured using its high-level and proprietary contacts throughout the meeting's duration

	ROGER LONGMAN is a managing partner at FDC-Windhover, an Elsevier Business Intelligence company. He has been involved with the health care industry for more than 20 years. In 1983, Mr. Longman joined The Wilkerson Group as a writer covering the pharmaceutical and biotech industries for IN VIVO: The Business & Medicine Report. In 1989, Longman along with David Cassak led a buyout of the Wilkerson Group's publications division, which they moved to Connecticut and renamed Windhover Information Inc. Since then Mr. Longman and Mr. Cassak have launched several new ventures including: Start-Up: Windhover’s Review of Emerging Medical Ventures;™ Strategic Transactions database, the industry’s most comprehensive and detailed database of industry M&A, alliances and financings; The RPM Report: Regulation • Policy • Market Access™, an analysis of key marketing, strategy and R&D implications of the changes in Washington at CMS and FDA; and a series of senior-executive conferences in corporate strategy, business development, R&D, and finance. In 2004, Windhover acquired Medtech Insight, an information company covering the medical device field through a market-leading newsletter, a series of in-depth market reports, and a number of conferences. In 2008, Windhover was acquired by Reed Elsevier. Under Elsevier, Mr. Longman runs a newly-created business unit that features several leading publications serving biopharma executives, including IN VIVO, Start-Up, The RPM Report and “The Pink Sheet,” “Pink Sheet Daily” and PharmAsia News, among others. In addition, the new unit will oversee biopharmaceutical conferences and partnering events, as well as and biopharmaceutical content in Windhover’s M&A, alliance, and financing transactions database. Over the years, Mr. Longman has become recognized as one of the leading experts in biopharmaceutical strategy and dealmaking. He is often asked to speak at many key industry events organized by important trade organizations like the Biotechnology Industry Organization (BIO), investment banks, venture capital firms and leading pharma and biotech companies. He lectures regularly at several leading universities. Mr. Longman completed his BA at Cornell University and an MA at the University of North Carolina at Chapel Hill, and then taught for three years at the European division of the University of Maryland.
	CHRISTOPHER MORRISON is the editor of Windhover's IN VIVO: The Business & Medicine Report, and was a staff writer for Windhover for the previous five years. Mr. Morrison and has primarily covered the European biopharmaceutical industry for IN VIVO, Start-Up and In Vivo Europe Rx. Prior to joining Windhover, Mr. Morrison was a New York-based freelance writer; his work has appeared in Nature Biotechnology, IEEE Spectrum, The Wall Street Journal Europe, The Financial Times and various other publications. Mr. Morrison holds a BS in neurobiology from Cornell University and an MA in journalism from NYU.
	ELLEN LICKING is finance bureau chief for Elsevier Business Intelligence.

What does registration get me?

• One (1) phone line, for you alone, or around which to gather your team(s). Toll-free in the U.S. only.
• One (1) password to a website on which you'll be taken through the presenters' slides as they speak to them.
• An interactive Q&A round with speakers: Type your questions on the website during the presentation, for the speakers to address afterward.
• Online access to the audio and slides of the entire event if you can't attend the webinar live, and still want to hear the content.
• The insight you've come to expect and respect from Windhover Webinars and our guest speakers.

• Convenience – and lower cost. Your entire team can listen in one room. No travel required!
• A team approach. You've often wanted to have everyone on your team getting the same knowledge and insight you derive from physical conferences. Now you can.
• Interactivity. You're remote, but not removed. Our webinars let you ask the important, burning, controversial questions of our speakers that you'd be able to pose at a physical conference.
• Flexibility. Want to be able to review what you learn? No problem ... just register for the live webinar PLUS a digital copy of the entire event to listen to at your convenience. Interested in the topic but have a scheduling conflict? Don't worry — the recording is available for purchase at any time!

Back to top

______________________________________________________________________
Windhover Webinars
Elsevier Business Intelligence
P.O. Box 7247
Philadelphia, PA 19101-9257
* Tel: +1 (800) 332-2181
or +1 (908) 547-2159
* Fax: +1 (908) 547-2165